When Less Chemo is Just As Good, In Treatment for Acute Myeloid Leukemia (AML)

Today’s issue of the New England Journal of Medicine includes an article with the bland title Cytarabine Dose for Acute Myeloid Leukemia. AML is an often-curable form of leukemia characterized by rapidly-growing myeloid white blood cells. Cytarabine – what we’d call “Ara-C” on rounds¬† – has been a mainstay of AML treatment for decades. The […]

Posted in cancer treatment, clinical trials, Oncology (cancer), Under the RadarTagged , , , , , , Leave a Comment on When Less Chemo is Just As Good, In Treatment for Acute Myeloid Leukemia (AML)